Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 192,103 | 165,453 | 149,824 | 174,159 | 175,689 |
| Cost of Goods | 18,965 | 16,827 | 15,763 | 26,098 | 17,583 |
| Gross Profit | 173,138 | 148,626 | 134,061 | 148,061 | 158,106 |
| Operating Expenses | 234,334 | 137,312 | 145,080 | 126,754 | 117,844 |
| Operating Income | -60,231 | 12,141 | -10,256 | 21,405 | 40,845 |
| Other Income | 2,277 | 4,528 | 4,425 | 4,977 | 4,098 |
| Pre-tax Income | -57,954 | 16,669 | -5,831 | 26,382 | 44,943 |
| Income Tax | -12,837 | -5,830 | 5,996 | 11,054 | 6,446 |
| Net Income Continuous | -45,117 | 22,499 | -11,827 | 15,328 | 38,497 |
| Net Income | $-45,117 | $22,499 | $-11,827 | $15,328 | $38,497 |
| EPS Basic Total Ops | -0.80 | 0.40 | -0.21 | 0.28 | 0.70 |
| EPS Basic Continuous Ops | -0.80 | 0.40 | -0.21 | 0.28 | 0.70 |
| EPS Diluted Total Ops | -0.80 | 0.40 | -0.21 | 0.27 | 0.69 |
| EPS Diluted Continuous Ops | -0.80 | 0.40 | -0.21 | 0.27 | 0.69 |
| EPS Diluted Before Non-Recurring Items | 0.46 | 0.78 | 0.28 | 0.61 | 0.95 |
| EBITDA(a) | $-36,346 | $33,467 | $9,053 | $39,576 | $61,913 |